Europe — EMA

Orfiril Injektionslösung (Sodium Valproate)

Request sourcing

Pack/s

What is Sodium Valproate?

Sodium Valproate, the active ingredient in Orfiril Injektionslösung, is an anticonvulsant presented as a solution for intravenous use. It is used to treat seizure disorders and is administered in hospital settings. GNH USA supplies Orfiril Injektionslösung as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Orfiril Injektionslösung as a licensed, GDP‑compliant international pharmaceutical ...

What is Sodium Valproate used for?

Orfiril Injektionslösung is ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →